Contact Us
About Us
Our Company
Our Leadership
Global Collaborations
Areas of Focus
Vaccines
Other Diseases
Pipeline
Science & Technology
Our Technology
COVID-19 Response
Manufacturing
Publications
Careers
Our Culture
Our Benefits
Our Positions
Investors
Corporate Governance
HKEX Filings
Financial Reports
IR Events
Presentations
IR Contact
News & Media
Company News
Media coverage
Contact Us
English
English
中文
Clover Biopharmaceuticals（HKEX: 2197）
Investor Relations
Corporate Governance
HKEX Filings
Financial Reports
IR Events
Presentations
IR Contact
Presentations
SCB-219M Preliminary Phase 1 Data
SCB-1019 (Bivalent RSV PreF-Trimer): Preliminary Phase 1 Young Adult Cohort Data
About Us
Areas of Focus
Pipeline
Science & Technology
Careers
Investors
News & Media
Contact Us
Terms of Use
Privacy Policy
Community Guidelines
©2023 Clover Biopharmaceuticals
蜀ICP备08004531号-1
川公网安备51019002003830号
SCB-219M Preliminary Phase 1 Data
